SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alliance Pharmaceutical
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
548 22 0 ALLP
Emcee:  All Mtn Ski Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
348 Polyheme is a human hemoglobin base blood substitute product with some studies Cacaito-5/6/1999
347 Ima-Rx and Dupont prevail in some patent dispute with Molecular Biosystems regaCacaito-5/6/1999
346 ALLP will present 17 papers at the American Thoracic Society - 1999 InternationDr. John M. de Castro-4/21/1999
345 I'd buy here - the stock won't be offered @ $2.50. They'll get somPaul Berliner-4/15/1999
344 All the three products Oxygent, Liquivent and Impagent are in Phase III. ImagenAlok Sinha-4/15/1999
343 Dilution. I guess everyone knew that something has to be done to fund the threubrx-4/14/1999
342 I have followed ALLP off and on for about 2 years now but never bought a share,ubrx-4/14/1999
341 Hextend approval by FDA for hypovolemia from blood loss. Abbott Labs will marCacaito-4/1/1999
340 That does not explain the 15% jump in price on good volume. Any news anybody ? Alok Sinha-3/11/1999
339 Hemosol will begin phase III trial. Competition in blood market. Hemosol was Cacaito-3/11/1999
338 I wonder if Alliance has some "Campaign to profitability"? This stockAll Mtn Ski-3/9/1999
337 Tom I'm going snowboarding Wednesday without a helmet. I 'm hoping toJohn R Resseger-3/9/1999
336 I think all ALLP investors that is certainly a cause of concern. The market wouAlok Sinha-2/16/1999
335 Question to all: Should I begin to worry that ALLP will run out of cash beforeJoinvestor-2/15/1999
334 Headlines -----------------------------------------------------------John R Resseger-2/1/1999
333 Fast track does not mean fast development, once development is completed then tCacaito-2/1/1999
332 I haven't forgoton you. John R Resseger-1/29/1999
331 John, Too bad FDA doesn't read Scientific American insted of the WallRobert C. Petersen-1/29/1999
330sciam.com February 1999 SA Mag piece on ALLP.John R Resseger-1/29/1999
329 From Utah Male ... (AOL FRODE ?) I was asked if I had any idea's about tJohn R Resseger-1/22/1999
328 Baxter, blood substitutes, lack of consent, and FDA problems: infobeat.com I Cacaito-1/18/1999
327 Bloos Substitutes Why does not the FDA Dick around with this for another 10 yeJohn R Resseger-1/5/1999
326 Alliance has a nice NEW investor summery on the web site.John R Resseger-1/4/1999
325 Du Pont files NDA for Definity (Perflutren) ultrasound contrast agent. It is sCacaito-12/9/1998
324 Thanks for the "dirt" on SKYL. Just bought more mall @ 25.5 :) Scott Saunders-11/19/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News